Parnell is focused on delivering innovative solutions to unmet animal health needs in the 70 billion dollar pet market.
We have core competences in drug discovery and development, regulatory filings, we have our own FDA approved manufacturing facility and we have a significant commercial presence in 14 countries.
Zydax is our lead compound that we’ve been marketing in Australia Zydax effectively regenerates cartilage and can literally save lives.
We’ve had one of our sales executives tell us a story of seeing a dog in a clinic that just four weeks earlier had been brought in to be euthanized. The pet parents had to carry the dog in, it couldn’t even walk.
After just four injections of Zydax the dog was bouncing around in the clinic, We will soon launch that drug in the United States and also Europe.